Figure 5 | Scientific Reports

Figure 5

From: Using population-based data to evaluate the impact of adherence to endocrine therapy on survival in breast cancer through the web-application BreCanSurvPred

Figure 5The alternative text for this image may have been generated using AI.

Snapshot of the web-based survival prediction application BreCanSurvPred. This snapshot shows the comparison of survival according to adherence to endocrine treatment for a 60-year old patient diagnosed with molecular subtype HER2 − /HR + in stage III. These survival probabilites are calculated up to 10 years after BC diagnosis. (Time: time since diagnosis [follow-up]; Percentage: percent survival at a certain Time ).

Back to article page